Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
17.70
Dollar change
-0.42
Percentage change
-2.32
%
IndexRUT P/E- EPS (ttm)-2.20 Insider Own3.28% Shs Outstand48.97M Perf Week7.14%
Market Cap866.95M Forward P/E- EPS next Y-0.97 Insider Trans-4.50% Shs Float47.37M Perf Month7.14%
Income-107.59M PEG- EPS next Q-0.33 Inst Own103.72% Short Float8.81% Perf Quarter9.73%
Sales233.25M P/S3.72 EPS this Y44.02% Inst Trans-0.41% Short Ratio9.17 Perf Half Y34.09%
Book/sh9.45 P/B1.87 EPS next Y21.44% ROA-9.94% Short Interest4.17M Perf Year-17.64%
Cash/sh9.33 P/C1.90 EPS next 5Y- ROE-19.06% 52W Range9.00 - 24.30 Perf YTD14.27%
Dividend Est.- P/FCF- EPS past 5Y-45.48% ROI-11.96% 52W High-27.16% Beta1.60
Dividend TTM- Quick Ratio11.16 Sales past 5Y78.51% Gross Margin35.60% 52W Low96.67% ATR (14)1.00
Dividend Ex-Date- Current Ratio11.73 EPS Y/Y TTM-137.82% Oper. Margin-25.14% RSI (14)58.38 Volatility5.81% 6.47%
Employees1170 Debt/Eq0.85 Sales Y/Y TTM-1.70% Profit Margin-46.12% Recom2.00 Target Price17.89
Option/ShortYes / Yes LT Debt/Eq0.84 EPS Q/Q-457.68% Payout- Rel Volume1.08 Prev Close18.12
Sales Surprise-1.94% EPS Surprise-362.41% Sales Q/Q-5.13% EarningsMar 12 AMC Avg Volume454.88K Price17.70
SMA206.34% SMA5011.16% SMA20019.03% Trades Volume490,420 Change-2.32%
Date Action Analyst Rating Change Price Target Change
Mar-13-24Reiterated Needham Buy $19 → $18
Aug-17-23Initiated Morgan Stanley Equal-Weight $16
Aug-10-23Downgrade Stephens Overweight → Equal-Weight $15
Jul-18-23Downgrade UBS Buy → Neutral $28 → $17
Jul-17-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Jul-13-23Downgrade SVB Securities Outperform → Market Perform $30 → $10
Jan-19-22Upgrade ROTH Capital Neutral → Buy $90
Nov-05-21Downgrade ROTH Capital Buy → Neutral $78 → $90
Oct-19-21Resumed B. Riley Securities Buy $81
Jul-16-21Initiated BTIG Research Buy $80
Mar-13-24 09:16AM
Mar-12-24 05:52PM
05:30PM
04:05PM
Feb-27-24 08:30AM
10:00AM Loading…
Feb-15-24 10:00AM
Feb-13-24 09:55AM
Nov-27-23 08:30AM
Nov-21-23 03:26PM
Nov-16-23 08:30AM
Nov-09-23 05:23PM
Nov-08-23 06:05PM
04:05PM
Nov-02-23 08:30AM
Oct-26-23 10:02AM
08:30AM Loading…
Oct-25-23 08:30AM
Oct-12-23 08:30AM
Oct-10-23 08:30AM
Oct-09-23 04:05PM
Sep-14-23 08:30AM
Aug-10-23 07:14AM
Aug-09-23 05:30PM
04:05PM
Aug-02-23 08:30AM
Jul-31-23 08:53AM
Jul-23-23 08:17AM
Jul-13-23 12:24PM
11:17AM
Jul-12-23 04:05PM
12:56PM
08:39AM Loading…
Jun-29-23 08:39AM
May-25-23 08:02AM
May-12-23 07:15AM
May-04-23 06:05PM
04:05PM
Apr-27-23 10:02AM
08:30AM
Apr-25-23 08:30AM
Apr-01-23 08:54AM
Mar-28-23 08:30AM
Mar-16-23 03:46AM
Mar-13-23 06:00AM
Mar-08-23 01:15PM
Feb-23-23 06:40PM
04:05PM
Feb-15-23 08:30AM
Jan-29-23 07:31AM
Jan-26-23 10:55AM
Jan-18-23 08:30AM
Dec-20-22 08:30AM
Dec-19-22 07:15AM
Nov-08-22 06:56AM
Nov-07-22 08:10PM
05:03AM
Nov-03-22 06:45PM
04:05PM
Oct-27-22 08:30AM
05:32AM
Sep-08-22 08:30AM
Aug-08-22 02:42PM
Aug-06-22 10:18AM
Aug-05-22 09:55AM
Aug-04-22 07:15PM
04:05PM
Jul-28-22 08:30AM
Jul-01-22 08:57AM
May-05-22 07:05PM
04:05PM
Apr-28-22 08:30AM
Apr-20-22 05:59PM
Apr-19-22 12:24PM
Apr-18-22 03:11PM
08:30AM
Mar-30-22 05:00PM
Mar-11-22 03:40PM
Feb-24-22 06:30PM
04:05PM
Feb-23-22 10:00AM
Feb-17-22 03:02PM
Feb-15-22 08:30AM
Feb-09-22 09:29AM
Feb-08-22 09:38AM
Feb-01-22 05:38PM
Jan-31-22 05:35PM
Jan-28-22 05:46AM
Jan-27-22 08:30AM
Jan-26-22 05:38PM
Jan-21-22 05:38PM
09:38AM
Jan-05-22 01:38PM
08:30AM
Dec-16-21 03:38AM
Dec-15-21 01:15PM
Dec-13-21 04:38PM
Dec-05-21 08:05AM
Nov-26-21 04:01PM
Nov-19-21 09:14AM
Nov-15-21 10:45AM
Nov-10-21 12:20AM
12:20AM
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHELTON JERRELLChief Executive OfficerMar 25 '24Sale17.542,63146,154692,182Mar 26 08:09 PM
Sawicki Mark WChief Scientific OfficerMar 25 '24Sale17.541,36723,98077,444Mar 26 08:08 PM
STEFANOVICH ROBERTChief Financial OfficerMar 25 '24Sale17.541,07918,928128,333Mar 26 08:12 PM
SHELTON JERRELLPresident, CEOMar 15 '24Option Exercise4.80100,000480,000749,253Mar 19 07:48 PM
Mandalam RamkumarDirectorMar 15 '24Option Exercise5.408,33445,00446,404Mar 19 07:49 PM
BADDOUR LINDADirectorMar 15 '24Option Exercise0.001,111021,690Mar 19 07:48 PM
SHELTON JERRELLPresident, CEOMar 15 '24Sale15.3057,039872,884634,352Mar 19 07:48 PM
Mandalam RamkumarDirectorMar 15 '24Sale14.683,21747,22643,187Mar 19 07:49 PM
Sawicki Mark WChief Scientific OfficerMar 15 '24Sale15.431,31220,24773,061Mar 19 07:50 PM
STEFANOVICH ROBERTChief Financial OfficerMar 15 '24Sale15.431,03515,972123,662Mar 19 07:51 PM
SHELTON JERRELLPresident, CEOMar 11 '24Sale16.353,72360,880636,951Mar 19 07:48 PM
Sawicki Mark WChief Scientific OfficerMar 11 '24Sale16.351,41823,18874,373Mar 19 07:50 PM
STEFANOVICH ROBERTChief Financial OfficerMar 11 '24Sale16.351,11918,298124,697Mar 19 07:51 PM
STEFANOVICH ROBERTChief Financial OfficerMar 09 '24Option Exercise0.002,6660125,816Mar 19 07:51 PM
SHELTON JERRELLPresident, CEOMar 09 '24Option Exercise0.008,2500640,674Mar 19 07:48 PM
Sawicki Mark WChief Scientific OfficerMar 09 '24Option Exercise0.002,666075,791Mar 19 07:50 PM
Hariri Robert JDirectorDec 14 '23Sale16.8980013,51212,716Dec 18 07:19 PM
Hariri Robert JDirectorDec 11 '23Sale15.501,00015,50013,516Dec 13 06:02 PM
Sawicki Mark WChief Scientific OfficerSep 12 '23Option Exercise12.791,00012,79073,125Sep 13 05:01 PM
Hariri Robert JDirectorSep 06 '23Sale13.601,50020,40014,516Sep 12 06:01 PM
SHELTON JERRELLSee RemarksSep 01 '23Option Exercise1.8754,000100,980659,299Sep 05 05:53 PM
SHELTON JERRELLSee RemarksSep 01 '23Sale14.2726,875383,407632,424Sep 05 05:53 PM
STEFANOVICH ROBERTChief Financial OfficerAug 29 '23Option Exercise3.0716,00049,120123,150Aug 30 05:30 PM
BERMAN RICHARD JDirectorMay 11 '23Sale21.517,203154,906100,000May 12 06:22 PM
SHELTON JERRELLPresident, CEOMay 10 '23Option Exercise3.24286,377927,861746,458May 12 06:22 PM
STEFANOVICH ROBERTChief Financial OfficerMay 10 '23Option Exercise3.2419,91864,534127,068May 12 06:21 PM
SHELTON JERRELLPresident, CEOMay 10 '23Sale21.63141,1593,053,509605,299May 12 06:22 PM
STEFANOVICH ROBERTChief Financial OfficerMay 10 '23Sale21.9419,918437,023107,150May 12 06:21 PM